Skip to main content

False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan

Abstract

I-123 metaiodobenzylguanidine (I-123 MIBG) scintigraphy is known for its high specificity in detecting pheochromocytoma and other tumors of neural crest origin. In this rare case report, we describe a definite adrenocortical adenoma that demonstrated false-positive uptake at I-123 MIBG scintigraphy and a remarkable accumulation of 75-SE-6-beta-selenomethyl-norcholesterol.

This is a preview of subscription content, access via your institution.

References

  1. Beierwaltes W.H. Update on basic research and clinical experience with metaiodobenzylguanidine. Med. Pediat. Oncol. 15: 163, 1987.

    CAS  Article  Google Scholar 

  2. Nakajo M., Shapiro B, Sisson J.C., Swanson D.P., Beierwaltes W.H. Salivary gland accumulation of meta-l-131-iodobenzylguanidine. J. Nucl. Med. 25: 2, 1984.

    CAS  PubMed  Google Scholar 

  3. Nakajo M., Shapiro B, Copp J., Kalff V., Gross M.D., Sisson J.C., Beierwaltes W.H. The normal and abnormal distribution of the adrenomedullary imaging agent l-131-iodobenzylguanidine (l-131 MIBG) in man; evaluation of scintigraphy. J. Nucl. Med. 24: 672, 1983.

    CAS  PubMed  Google Scholar 

  4. Sisson J., Wieland D. Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. Am. J. Physiol. Imaging 1: 96, 1986.

    CAS  PubMed  Google Scholar 

  5. Hanson M.W., Feldman J.M., Beam C.A., Leight G.S., Coleman R.E. Iodine-131-labeled metaiodobenzylguanidine scintigraphy and biochemical analysis in suspected pheochromocytoma. Arch. Intern. Med. 151: 1397, 1991.

    CAS  PubMed  Article  Google Scholar 

  6. Mozley P.D., Kim C.K., Mohsin J., Jatlow A., Gossfield III E., Alavi A. The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma. J. Nucl. Med. 35: 1138, 1994.

    CAS  PubMed  Google Scholar 

  7. Ackery D.M., Tippett P.A., Condon B.R., Sutton H.E., Wyeth P. New approach to the localization of pheochromocytoma; imaging with lodine-131- metaiodobenzylguanidine. Br. Med. J. 288: 1587, 1984.

    CAS  Article  Google Scholar 

  8. Bravo E.L., Gifford R.W. Pheochromocytoma: diagnosis, localization and management. N. Engl. J. Med. 311: 1298, 1984.

    CAS  PubMed  Article  Google Scholar 

  9. Chatal F., Charbonnel B. Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma. J. Clin. Endocrinol. Metab. 61: 769, 1985.

    CAS  PubMed  Article  Google Scholar 

  10. Velchik M.G., Alavi A., Kressel H.Y., Engelman K. Localization of pheochromocytoma: MIBG, CT and MRI correlation. J. Nucl. Med. 30: 328, 1989.

    CAS  PubMed  Google Scholar 

  11. Letizia C., Scavo D. Meta-iodobenzylguanidine seen in the diagnosis of pathologic conditions of the adrenal medulla: pheochromocytoma. Arch. Intern. Med. 150: 1541, 1990.

    CAS  PubMed  Article  Google Scholar 

  12. Shapiro B., Copp J.E., Sisson J.C., Eyre P.L., Wallis J., Beierwaltes W.H. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experiences in 400 cases. J. Nucl. Med. 26: 576, 1985.

    CAS  PubMed  Google Scholar 

  13. Shapiro B. Summary, conclusions and future directions of 131-l-metaiodobenzylguanidine therapy in the treatment of neural crest tumors. J. Nucl. Biol. Med. 35: 357, 1993.

    Google Scholar 

  14. Jacobs A., Lenoir P., Delree M., Ramet J., Piepsz A. Unusual 99m-TC-MDP and 123-MIBG images in focal pyelonephritis. Clin. Nucl. Med. 15: 821, 1990.

    CAS  PubMed  Article  Google Scholar 

  15. Hanson M., Feldman J., Beam C., Leight G., Coleman R. Iodine-131-labeled metaiodobenzylguanidine scintigraphy and biochemical analysis in suspected pheochromocytoma. Arch. Intern. Med. 151: 1397, 1991.

    CAS  PubMed  Article  Google Scholar 

  16. Feggi L., Liberti E., Pansini G., Transforini G., Prandini N., Ambrosio M., D’urso A., Faggioli R. Pitfalls in scintigraphic detection of neuroendocrine tumors. Eur. J. Nucl. Med. 19: 214, 1992.

    CAS  PubMed  Article  Google Scholar 

  17. Gallar P., Qliet A., Hernandez E., Vigil A., Ortege O. Renal failure as a cause of false positive results on metaiodobenzylguanidine scan. Nephrol. Dial. Transplant. 481 (Letter), 1993.

  18. Bathmann J., Neumann H., Sigmund G., Moser E. False-positive diagnosis of a pheochromocytoma with 1–123 metaiodobenzylguanidine. Clin. Nucl. Med. 19: 221, 1994.

    CAS  PubMed  Article  Google Scholar 

  19. Krubsack A., Arnaut M., Hagen T., Zielonka J., Choi H., Akhtar R., Schulte W. Zona fasciculata cortical adenoma and adrenal medullary hyperplasia in MEN II patient: unique concurrent presentation. Clin. Nucl. Med. 13: 730, 1988.

    CAS  PubMed  Article  Google Scholar 

  20. Home T., Glaser B., Krausz Y., Rubinger D., Britton K.E. Unusual causes of 1–131-metaiodobenzylguanidine uptake in non-neural crest tissue. Clin. Nucl. Med. 16: 239, 1991.

    Article  Google Scholar 

  21. Sone H., Okuda Y., Nakamura Y., Ishikawa N., Yamaoka T., Odawara M., Matsushima T., Kawai K, Yamashita K. Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma: a false-positive case of adrenocortical adenoma and literature review. Horm. Res. 46: 138, 1996.

    CAS  PubMed  Article  Google Scholar 

  22. Houghton A., Clarke S., Jourdan M. False-positive diagnosis of adrenal pheochromocytoma on metaiodobenzylguanidine (MIBG) scan. Br. J. Clin. Pharmacol. 44: 411, 1990.

    CAS  Google Scholar 

  23. Alasabeh R., Mazoujian G., Goates J., Medeiros J., Weiss L.M. Adrenal cortical tumors clinically mimicking pheochromocytoma. Am. J. Clin. Pathol. 104: 382, 1995.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Letizia, C., De Toma, G., Massa, R. et al. False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan. J Endocrinol Invest 21, 779–783 (1998). https://doi.org/10.1007/BF03348046

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348046

Key-words

  • I-123 metaiodobenzylguanidine scintigraphy
  • false-positive result
  • adrenocortical adenoma